PARP inhibitor olaparib increases the oncolytic activity of dl922-947 in invitro and invivo model of anaplastic thyroid carcinoma

1. Passaro, C.
2. Volpe, M.
3. Botta, G.
4. Scamardella, E.
5. Perruolo, G.
6. Gillespie, D.
7. Libertini, S.
8. Portella, G.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.MOLONC.2014.07.022 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus